Apimeds Pharmaceuticals US, Inc. (APUS)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.71-0.92%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-20.2M

EPS

$-11.77

Market cap

$4.1M

Forward P/E

0.0

P/B

0.04

Book value

$0.65

EPS (TTM)

$-36.03

52-week high

$40.31

52-week low

$1.51

50-day MA

$3.58

200-day MA

$10.69

Insiders

58.70%

Institutions

2.83%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apimeds Pharmaceuticals US, Inc. — free to start.

Data updated 2026-11-07.